Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians

Stroke

Volumn 41, Issue 8, 2010, Pages 1833-1835

  Mateen, Farrah J ^a   Buchan, Alastair M ^b   Hill, Michael D ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

acute ischemic stroke; nonagenarian; oldest old; thrombolysis; tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE SEVERITY; ELDERLY CARE; FEMALE; HUMAN; HYPERTENSION; MALE; MORTALITY; NONAGENARIAN; OCTOGENARIAN; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

AGE FACTORS; AGED, 80 AND OVER; BRAIN ISCHEMIA; CANADA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; REGISTRIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 77955171312     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.586438     Document Type: Article

References (14)

1. International Year of Older Persons: Demographics of Older Persons. United Nations Department of Public Information Web Site. September 1999. http://www.un.org/NewLinks/older/99/older.htm Accessed October 23 2009.
2. Elkins JS, Johnston SC. Thirty-year projections for deaths from ischemic stroke in the United States. Stroke. 2003;34:2109-2112.
3. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischemic stroke. Cochrane Database Syst Rev. 2009;4:CD000213.
4. Hill MD, Buchan AM; CASES Investigators. Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES). Can J Neurol Sci. 2001;28:232-238.
5. Sylaja PN, Cote R, Buchan M, Hill MD; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry. 2006;77:826-829.
6. Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005; 172:1307-1312.
7. The European Agency for the Evaluation of Medicinal Products. Summary information on a referral opinion following an arbitration pursuant to Article 29 of Directive 2001/83/EC for Actylise. http://www.emea.europa.eu/pdfs/human/ referral/Actilyse/334602en.pdf Accessed December 8, 2009.
8. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? Neurology. 2001;56:1015-1020.
9. Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Low-itzsch K, Heidrich J, Hermanek P, Leffmann C, Sitzer M, Biegler M, Buecker-Nott HJ, Berger K; German Stroke Registers Study Group. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. J Am Med Assoc. 2004;292: 1831-1838.
10. Kammersgaard LP, Jørgensen HS, Reith J, Nakayama H, Pedersen PM, Olsen TS. Short-and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study. Age Aging. 2004;33:149-154.
11. Mateen FJ, Nasser M, Spencer BR, Freeman WD, Shuaib A, Wijdicks EFM. Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc. 2009;84:334-338
12. NINDS t-PA Stroke Study Group Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997; 28:2119-2125.
13. Berrouschot J, Rother J, Glahn J, Kucinski T, Fiehler J, Thomalla G. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (>80 years) stroke patients. Stroke. 2005;36:2421-2425.
14. Di Carlo A, Lamassa M, Pracucci G, Basile A, Trefoloni G, Vanni P, Wolfe CD, Tilling K, Ebrahim S, Inzitari D. Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: a European perspective. European BIOMED Study of Stroke Care Group. Stroke. 1999;30:2313-2319.